Recently, it has been reported that this molecule and even the SOCS1-mimetic peptide Tkip [45,46] can modulate anti-tumor immunity depending on its expression level in anti-tumor lymphocytes and tumor cells via diverse mechanisms [47]. This evidence concerns the gene SOCS1 and neoplasm.